Discovery of Chalcone-Based Hybrid Structures as High Affinity and Site-Specific Inhibitors against SARS-CoV-2: A Comprehensive Structural Analysis Based on Various Host-Based and Viral Targets
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24108789 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Mehdi Valipour und 3 weiteren Autor:innen. Beteiligte Einrichtung: Razi Drug Research Center, Iran University of Medical Sciences, Tehran 1545913487, Iran. Hauptthemen laut MEDLINE: COVID-19, Chalcones, Chalcone. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mazandaran University of Medical Sciences (MAZUMS).
Abstract (Originalsprache)
Previous studies indicated that natural-based chalcones have significant inhibitory effects on the coronavirus enzymes 3CLpro and PLpro as well as modulation of some host-based antiviral targets (HBATs). In this study, a comprehensive computational and structural study was performed to investigate the affinity of our compound library consisting of 757 chalcone-based structures (CHA-1 to CHA-757) for inhibiting the 3CLpro and PLpro enzymes and against twelve selected host-based targets. Our results indicated that CHA-12 (VUF 4819) is the most potent and multi-target inhibitor in our chemical library over all viral and host-based targets. Correspondingly, CHA-384 and its congeners containing ureide moieties were found to be potent and selective 3CLpro inhibitors, and benzotriazole moiety in CHA-37 was found to be a main fragment for inhibiting the 3CLpro and PLpro. Surprisingly, our results indicate that the ureide and sulfonamide moieties are integral fragments for the optimum 3CLpro inhibition while occupying the S1 and S3 subsites, which is fully consistent with recent reports on the site-specific 3CLpro inhibitors. Finding the multi-target inhibitor CHA-12, previously reported as an LTD4 antagonist for the treatment of inflammatory pulmonary diseases, prompted us to suggest it as a concomitant agent for relieving respiratory symptoms and suppressing COVID-19 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Razi Drug Research Center, Iran University of Medical Sciences, Tehran 1545913487, Iran.
- Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.
- Department of Medicinal Chemistry, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari 4847116547, Iran.
ORCID-Profile: Mehdi Valipour, Silvia Di Giacomo, Antonella Di Sotto, Hamid Irannejad
Förderung
- Mazandaran University of Medical Sciences (MAZUMS)
Zitieren
APA
Valipour, M., Di Giacomo, S., Di Sotto, A., & Irannejad, H. (2023). Discovery of Chalcone-Based Hybrid Structures as High Affinity and Site-Specific Inhibitors against SARS-CoV-2: A Comprehensive Structural Analysis Based on Various Host-Based and Viral Targets. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24108789
Vancouver
Valipour M, Di Giacomo S, Di Sotto A, Irannejad H. Discovery of Chalcone-Based Hybrid Structures as High Affinity and Site-Specific Inhibitors against SARS-CoV-2: A Comprehensive Structural Analysis Based on Various Host-Based and Viral Targets. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24108789
BibTeX
@article{Valipour2023,
author = {Valipour, Mehdi and Di Giacomo, Silvia and Di Sotto, Antonella and Irannejad, Hamid},
title = {Discovery of Chalcone-Based Hybrid Structures as High Affinity and Site-Specific Inhibitors against SARS-CoV-2: A Comprehensive Structural Analysis Based on Various Host-Based and Viral Targets},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24108789}
}
EUVIMED